Abstract
Data are presented covering various studies on the use of the phosphodiesterase inhibitor pentoxifylline (PF) in the sperm preparation for procedures in assisted reproduction. Significant improvements have been shown in the fertilization rate of oocytes along with a reduced risk of failed fertilization cycles utilizing oligo/asthenozoospermic semen samples. Fertilization is also improved for normozoospermic samples when the acrosome reaction is suboptimal. PF has proven effects on sperm motility, increasing the proportion of hyperactivated spermatozoa. It can also enhance the acrosome reaction and this may be the more relevant function for clinical prediction. There is a further action as a suppressor or scavenger of reactive oxygen species although higher concentrations than that in current clinical use may be required to optimize this effect. PF should be washed out of the sample used for insemination to avoid inhibiting the completion of oocyte maturation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
